Marcus J. Schultz

Professor, (Principal Investigator), Prof. MD PhD

1991 …2022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Professor Schultz completed his medical degree (with distinction) and residency in Internal Medicine at the University of Amsterdam (UvA) and the Academic Medical Center (AMC), Amsterdam, The Netherlands. He obtained his doctorate at the same university.

Professor Schultz is an ICU consultant and one of the Principal Investigators of the AMC, and professor of Experimental Intensive Care Medicine at the UvA. Marcus Schultz is the founder of the ‘PROtective VEntilation Network’ (, a worldwide collaboration of intensivists and anaesthesiologists in ventilation research that successfully completed several large randomised clinical trials. He initiates national and international projects aiming at implementation of intensive care unit strategies in resource–rich and resource–restricted critical care settings in Europe, SE Asia, Africa and South–America.

As the former chair of the ‘Laboratory of Experimental Intensive Care and Anaesthesiology’ (L·E·I·C·A), a university–based laboratory specialized in translational research in the field of mechanical ventilation, and as head of research at the ICU of the AMC, Marcus Schultz runs a large international research group focusing on translational, preclinical and clinical research in the fields of invasive ventilation, lung imaging, lung protection, and infection prevention strategies in critical illness. Marcus Schultz’s group is highly productive, publishing numerous scientific articles in peer-reviewed international journals and various chapters in medical books each year.

Marcus Schultz is announcing he is taking an indefinite leave of absence from the Department of Intensive Care at the Amsterdam University Medical Centers (location AMC) to join Hamilton Medical AG as the Leader of Medical Affairs. Hamilton Medical AG is a leading manufacturer of critical care ventilation solutions for a variety of patient populations, applications, and environments. As such he will be based in Chur, Switzerland. Dr. Schultz will retain his faculty appointment at the University of Amsterdam and continue to attend at the AMC. His leave of absence wil be effective January 1, 2022.


Intensive Care


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or